Pfizer sells off partial stake in Haleon, potentially raising $2B+
Following in GSK’s footsteps, Pfizer is selling off about 630 million shares of its stake in consumer health spinoff Haleon, reducing the Big Pharma’s stake …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.